The combination of vitamins and omega-3 fatty acids has an enhanced anti-inflammatory effect on microglia

Neurochemistry International

Volumn 99, Issue , 2016, Pages 206-214

  Kurtys, E ^a   Eisel, U L M ^b   Verkuyl, J M ^c   Broersen, L M ^c   Dierckx, R A J O ^a   de Vries, E F J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c DANONE NUTRICIA RESEARCH   (Netherlands)

Author keywords

Fatty acids; Microglia; Neuroinflammation; Nutrition; Retinoic acid receptor ; Vitamins

Indexed keywords

CELL NUCLEUS RECEPTOR; CYANOCOBALAMIN; CYSTEINE; DOCOSAHEXAENOIC ACID; FOLIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PYRIDOXINE; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR; RETINOL; TRYPTOPHAN; VITAMIN D; VITAMIN D RECEPTOR; ANTIINFLAMMATORY AGENT; AUTACOID; OMEGA 3 FATTY ACID; VITAMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUTRIENT CONCENTRATION; NUTRIENT CONTENT; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; COMBINATION DRUG THERAPY; DRUG EFFECTS; INFLAMMATION; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DRUG THERAPY, COMBINATION; FATTY ACIDS, OMEGA-3; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICROGLIA; VITAMIN A; VITAMIN D; VITAMINS;

EID: 84979917740     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2016.07.008     Document Type: Article

References (46)

1. Ahmad, A., Ali, T., Park, H.Y., Badshah, H., Rehman, S.U., Kim, M.O., Neuroprotective effect of fisetin against amyloid-beta-induced cognitive/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Mol. Neurobiol., 2016, 10.1007/s12035-016-9795-4.
2. Ahmad, A., Shah, S.A., Badshah, H., Kim, M.J., Ali, T., Yoon, G.H., et al. Neuroprotection by vitamin C against ethanol-induced neuroinflammation associated neurodegeneration in the developing rat brain. CNS Neurol. Disord. Drug Targets 15 (2016), 360–370.
3. Bob, P., Raboch, J., Maes, M., Susta, M., Pavlat, J., Jasova, D., et al. Depression, traumatic stress and interleukin-6. J. Affect Disord. 120 (2010), 231–234, 10.1016/j.jad.2009.03.017.
4. Chen, J.-C., Ho, F.-M., Pei-Dawn Lee, Chao, Chen, C.-P., Jeng, K.-C.G., Hsu, H.-B., et al. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur. J. Pharmacol. 521 (2005), 9–20, 10.1016/j.ejphar.2005.08.005.
5. Chen, Y., Zhang, J., Ge, X., Du, J., Deb, D.K., Li, Y.C., Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. J. Biol. Chem. 288 (2013), 19450–19458, 10.1074/jbc.M113.467670.
6. Clark, R.B., The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71 (2002), 388–400.
7. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S., Snyder, S.H., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 88 (1991), 6368–6371.
8. Dawson, H.D., Collins, G., Pyle, R., Key, M., Taub, D.D., The Retinoic Acid Receptor-alpha mediates human T-cell activation and Th2 cytokine and chemokine production. BMC Immunol., 9, 2008, 16, 10.1186/1471-2172-9-16.
9. Del Angel-Meza, A.R., Dávalos-Marín, A.J., Ontiveros-Martinez, L.L., Ortiz, G.G., Beas-Zarate, C., Chaparro-Huerta, V., et al. Protective effects of tryptophan on neuro-inflammation in rats after administering lipopolysaccharide. Biomed. Pharmacother. 65 (2011), 215–219, 10.1016/j.biopha.2011.02.008.
10. Diep, Q.N., Touyz, R.M., Schiffrin, E.L., Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 36 (2000), 851–855.
11. Doorduin, J., de Vries, E.F.J., Willemsen, A.T.M., de Groot, J.C., Dierckx, R.A., Klein, H.C., Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med. 50 (2009), 1801–1807, 10.2967/jnumed.109.066647.
12. Dzhagalov, I., Chambon, P., He, Y.-W., Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. J. Immunol. 178 (2007), 2113–2121.
13. Fan, T., Jiang, W.L., Zhu, J., Feng Zhang, Y., Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation. Biol. Pharm. Bull. 35 (2012), 2004–2009.
14. Fritz, C.O., Morris, P.E., Richler, J.J., Effect size estimates: current use, calculations, and interpretation. J. Exp. Psychol. Gen. 141 (2012), 2–18, 10.1037/a0024338.
15. Germain, P., Gaudon, C., Pogenberg, V., Sanglier, S., Van Dorsselaer, A., Royer, C.A., et al. Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists. Chem. Biol. 16 (2009), 479–489, 10.1016/j.chembiol.2009.03.008.
16. Gill, N., Bijjem, K.R.V., Sharma, P.L., Anti-inflammatory and anti-hyperalgesic effect of all-trans retinoic acid in carrageenan-induced paw edema in Wistar rats: involvement of peroxisome proliferator-activated receptor-β/δ receptors. Indian J. Pharmacol. 45 (2013), 278–282, 10.4103/0253-7613.111944.
17. Gresa-Arribas, N., Viéitez, C., Dentesano, G., Serratosa, J., Saura, J., Solà, C., Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents. PLoS One, 7, 2012, e45227, 10.1371/journal.pone.0045227.
18. Haarman, B.C.M.B., Riemersma-Van der Lek, R.F., de Groot, J.C., Ruhé, H.G.E., Klein, H.C., Zandstra, T.E., et al. Neuroinflammation in bipolar disorder - a [(11)C]-(R)-PK11195 positron emission tomography study. Brain Behav. Immun. 40 (2014), 219–225, 10.1016/j.bbi.2014.03.016.
19. Henn, A., Lund, S., Hedtjärn, M., Schrattenholz, A., Pörzgen, P., Leist, M., The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26 (2009), 83–94.
20. Huo, L., Cui, D., Yang, X., Gao, Z., Trier, K., Zeng, J., All-trans retinoic acid modulates mitogen-activated protein kinase pathway activation in human scleral fibroblasts through retinoic acid receptor beta. Mol. Vis. 19 (2013), 1795–1803.
21. Hur, J., Lee, P., Kim, M.J., Cho, Y.-W., Regulatory effect of 25-hydroxyvitamin D3 on nitric oxide production in activated microglia. Korean J. Physiol. Pharmacol. 18 (2014), 397–402, 10.4196/kjpp.2014.18.5.397.
22. Jacka, F.N., Pasco, J.A., Mykletun, A., Williams, L.J., Hodge, A.M., O'Reilly, S.L., et al. Association of Western and traditional diets with depression and anxiety in women. Am. J. Psychiatry 167 (2010), 305–311, 10.1176/appi.ajp.2009.09060881.
23. Kang, C.-H., Choi, Y.H., Moon, S.-K., Kim, W.-J., Kim, G.-Y., Quercetin inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-κB pathway and activating the Nrf2-dependent HO-1 pathway. Int. Immunopharmacol. 17 (2013), 808–813, 10.1016/j.intimp.2013.09.009.
24. Kim, C.J., Kovacs-Nolan, J., Yang, C., Archbold, T., Fan, M.Z., Mine, Y., L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis. Biochim. Biophys. Acta 1790 (2009), 1161–1169, 10.1016/j.bbagen.2009.05.018.
25. Korhonen, R., Lahti, A., Kankaanranta, H., Moilanen, E., Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy 4 (2005), 471–479.
26. Krause, D.L., Müller, N., Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int. J. Alzheimers Dis., 2010, 2010, 10.4061/2010/732806.
27. Labrousse, V.F., Nadjar, A., Joffre, C., Costes, L., Aubert, A., Grégoire, S., et al. Short-term long chain Omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. PLoS One, 7, 2012, e36861, 10.1371/journal.pone.0036861.
28. Le, Q., Dawson, M.I., Soprano, D.R., Soprano, K.J., Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids. Oncogene 19 (2000), 1457–1465, 10.1038/sj.onc.1203436.
29. Lee, J.-K., Tran, T., Tansey, M.G., Neuroinflammation in Parkinson's disease. J. Neuroimmune Pharmacol. 4 (2009), 419–429, 10.1007/s11481-009-9176-0.
30. Lee, S.A., Kim, H.J., Chang, K.C., Baek, J.C., Park, J.K., Shin, J.K., et al. DHA and EPA down-regulate COX-2 expression through suppression of NF-kappaB activity in LPS-treated human umbilical vein endothelial cells. Korean J. Physiol. Pharmacol. 13 (2009), 301–307, 10.4196/kjpp.2009.13.4.301.
31. Lefebvre d'Hellencourt, C., Montero-Menei, C.N., Bernard, R., Couez, D., Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J. Neurosci. Res. 71 (2003), 575–582, 10.1002/jnr.10491.
32. Leonard, B.E., The concept of depression as a dysfunction of the immune system. Curr. Immunol. Rev. 6 (2010), 205–212, 10.2174/157339510791823835.
33. Li, Y., Lv, O., Zhou, F., Li, Q., Wu, Z., Zheng, Y., Linalool inhibits LPS-induced inflammation in BV2 microglia cells by activating Nrf2. Neurochem. Res. 40 (2015), 1520–1525, 10.1007/s11064-015-1629-7.
34. Lourida, I., Soni, M., Thompson-Coon, J., Purandare, N., Lang, I.A., Ukoumunne, O.C., et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 24 (2013), 479–489, 10.1097/EDE.0b013e3182944410.
35. Lu, D.-Y., Tsao, Y.-Y., Leung, Y.-M., Su, K.-P., Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids. Neuropsychopharmacology 35 (2010), 2238–2248, 10.1038/npp.2010.98.
36. Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 24 (2009), 27–53, 10.1007/s11011-008-9118-1.
37. Manshouri, T., Yang, Y., Lin, H., Stass, S.A., Glassman, A.B., Keating, M.J., et al. Downregulation of RAR alpha in mice by antisense transgene leads to a compensatory increase in RAR beta and RAR gamma and development of lymphoma. Blood 89 (1997), 2507–2515.
38. Mathew, J.S., Sharma, R.P., Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int. J. Immunopharmacol. 22 (2000), 693–706.
39. Moon, D.-O., Kim, K.-C., Jin, C.-Y., Han, M.-H., Park, C., Lee, K.-J., et al. Inhibitory effects of eicosapentaenoic acid on lipopolysaccharide-induced activation in BV2 microglia. Int. Immunopharmacol. 7 (2007), 222–229, 10.1016/j.intimp.2006.10.001.
40. Pascual, G., Fong, A.L., Ogawa, S., Gamliel, A., Li, A.C., Perissi, V., et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437 (2005), 759–763, 10.1038/nature03988.
41. Pettit, L.K., Varsanyi, C., Tadros, J., Vassiliou, E., Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin. Lipids Health Dis., 12, 2013, 16, 10.1186/1476-511X-12-16.
42. Rincon, M., Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol. 33 (2012), 571–577, 10.1016/j.it.2012.07.003.
43. Selhub, J., Jacques, P.F., Bostom, A.G., Wilson, P.W., Rosenberg, I.H., Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev. 28 (2000), 117–145.
44. Skarupski, K.A., Tangney, C.C., Li, H., Evans, D.A., Morris, M.C., Mediterranean diet and depressive symptoms among older adults over time. J. Nutr. Health Aging 17 (2013), 441–445, 10.1007/s12603-012-0437-x.
45. Suzuki, K., Takahashi, K., Nishimaki-Mogami, T., Kagechika, H., Yamamoto, M., Itabe, H., Docosahexaenoic acid induces adipose differentiation-related protein through activation of retinoid x receptor in human choriocarcinoma BeWo cells. Biol. Pharm. Bull. 32 (2009), 1177–1182.
46. Swamidas, G.P., Basaraba, R.J., Baybutt, R.C., Dietary retinol inhibits inflammatory responses of rats treated with monocrotaline. J. Nutr. 129 (1999), 1285–1290.